Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 41, Issue 6, Pages (December 2004)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
Primary prevention of variceal haemorrhage: A pharmacological approach
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Non-invasive diagnosis of non-alcoholic fatty liver disease
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Virological tools to diagnose and monitor hepatitis C virus infection
Volume 66, Issue 1, Pages 1-4 (January 2017)
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 
Economics of chronic hepatitis B and hepatitis C
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Non-invasive evaluation of liver fibrosis using transient elastography
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
Volume 62, Issue 3, Pages (March 2015)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Volume 66, Issue 4, Pages (April 2017)
Volume 142, Issue 6, Pages e4 (May 2012)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
The relationship between age and fat infiltration in liver and muscle
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C  Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology  Volume 48, Issue 5, Pages 882-884 (May 2008) DOI: 10.1016/j.jhep.2008.01.018 Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Pragmatic algorithm for the use of non-invasive tests. (1) APRI<0.5 and Fibrotest<0.22, or any combination with NPV close to 100%. (2) APRI<1.5 and Fibrotest<0.46, or Fibrometer excluding F3F4, or Fibroscan<11.7KPa. (3) Clinical examination+US, Fibrometer giving F4, APRI>2 and Fibrotest>0.59 or any combination PPV close to 100%. Journal of Hepatology 2008 48, 882-884DOI: (10.1016/j.jhep.2008.01.018) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.